<?xml version="1.0"?>
<law>
  <structure>
    <unit label="article" identifier="ghg" order_by="" level="1">Health - General</unit>
  </structure>
  <section_number>ghg-15-124</section_number>
  <catch_line>...</catch_line>
  <order_by>124</order_by>
  <text>
    <section prefix="(a)">The Department shall maintain a Maryland Pharmacy Assistance Program for low income individuals not eligible for Medicare whose:<section prefix="(1)">Assets are not more than the level established by the federal Centers for Medicare and Medicaid Services under the Qualified Medicare Beneficiary Program; and</section><section prefix="(2)">Gross annual income does not exceed 116% of the federal poverty guidelines for an individual, or 100% of the federal poverty guidelines for a family of two or more.</section></section>
    <section prefix="(b)">
      <section prefix="(1)">
        <section prefix="(i)">Reimbursement under the Maryland Pharmacy Assistance Program may be limited to maintenance drugs, anti-infectives, and AZT as specified in regulations to be issued by the Secretary after consultation with the Maryland Pharmacists Association.</section>
        <section prefix="(ii)">
          <section prefix="1.">For any drug on the Program's interchangeable drug list, the Program shall reimburse providers in an amount not more than it would reimburse for the drug's generic equivalent, unless the individual's physician states, in his or her own handwriting, on the face of the prescription, that a specific brand is "medically necessary" for the particular patient.</section>
          <section prefix="2.">If an appropriate generic drug is not generally available, the Department may waive the reimbursement requirement under subsubparagraph 1 of this subparagraph.</section>
        </section>
      </section>
      <section prefix="(2)">The reimbursement shall be up to the amount paid for the same items or services under the pharmacy program of the Maryland Medical Assistance Program and shall be subject to a copayment of not more than:<section prefix="(i)">$2.50 for a generic drug or a brand name drug on a preferred drug list established by the Department; and</section><section prefix="(ii)">$7.50 for a brand name drug not on a preferred drug list established by the Department.</section></section>
    </section>
    <section prefix="(c)">
      <section prefix="(1)">Except as provided under paragraph (4) of this subsection and unless the change is made by an emergency regulation, the Maryland Pharmacy Assistance Program shall notify all pharmacies under contract with the Program in writing of changes in the Pharmaceutical Benefit Program rules or requirements at least 30 days before the change is effective.</section>
      <section prefix="(2)">Changes that require 30 days' advance written notice under paragraph (1) of this subsection are:<section prefix="(i)">Exclusion of coverage for classes of drugs as specified by contract;</section><section prefix="(ii)">Changes in prior or preauthorization procedures; and</section><section prefix="(iii)">Selection of new prescription claims processors.</section></section>
      <section prefix="(3)">If the Maryland Pharmacy Assistance Program fails to provide advance notice as required under paragraph (1) of this subsection, it shall honor and pay in full any claim under the Program rules or requirements that existed before the change for 30 days after the postmarked date of the notice.</section>
      <section prefix="(4)">Notwithstanding any other provision of law, the notice requirements of this subsection do not apply to the addition of new generic drugs authorized under &#xA7; 12-504 of the Health Occupations Article.</section>
    </section>
    <section prefix="(d)">
      <section prefix="(1)">The Secretary shall adopt rules and regulations that authorize the denial, restriction, or termination of eligibility for recipients who have abused benefits under the Maryland Pharmacy Assistance Program.</section>
      <section prefix="(2)">As a condition of participation, the Department may require Maryland Pharmacy Assistance Program participants to apply for eligibility in the Maryland Medical Assistance Program within 60 days of notification to do so by the Department.</section>
      <section prefix="(3)">The rules and regulations shall require that the recipient be given notice and an opportunity for a hearing before eligibility may be denied, restricted, or terminated under this subsection.</section>
    </section>
    <section prefix="(e)">The Secretary shall develop a program, in consultation with appropriate agencies, that will provide information to ineligible Maryland Pharmacy Assistance Program applicants regarding other programs that they may be eligible for including the Maryland Medbank Program established under &#xA7; 15-124.2 of this subtitle and the Senior Prescription Drug Assistance Program established under Title 14, Subtitle 5 of the Insurance Article.</section>
  </text>
</law>
